Correlation Between Citigroup and Taigen Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both Citigroup and Taigen Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Taigen Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Citigroup and Taigen Biopharmaceuticals Holdings, you can compare the effects of market volatilities on Citigroup and Taigen Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Taigen Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Taigen Biopharmaceutica.

Diversification Opportunities for Citigroup and Taigen Biopharmaceutica

0.3

Correlation Coefficient

Citigroup  Taigen Biopharmaceutica

Weak diversification

The 3 months correlation between Citigroup and Taigen is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Taigen Biopharmaceuticals Hold in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taigen Biopharmaceutica and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Taigen Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taigen Biopharmaceutica has no effect on the direction of Citigroup i.e., Citigroup and Taigen Biopharmaceutica go up and down completely randomly.

Pair Corralation between Citigroup and Taigen Biopharmaceutica

Taking into account the 90-day investment horizon Citigroup is expected to generate 1.1 times more return on investment than Taigen Biopharmaceutica. However, Citigroup is 1.1 times more volatile than Taigen Biopharmaceuticals Holdings. It trades about 0.03 of its potential returns per unit of risk. Taigen Biopharmaceuticals Holdings is currently generating about -0.02 per unit of risk. If you would invest  6,991  in Citigroup on December 29, 2024 and sell it today you would earn a total of  194.00  from holding Citigroup or generate 2.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	91.8%
Values	Daily Returns

Citigroup  vs.  Taigen Biopharmaceuticals Hold

Citigroup

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Citigroup is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Taigen Biopharmaceutica

Risk-Adjusted Performance

Very Weak

Over the last 90 days Taigen Biopharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Taigen Biopharmaceutica is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Citigroup and Taigen Biopharmaceutica

The main advantage of trading using opposite Citigroup and Taigen Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Taigen Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taigen Biopharmaceutica will offset losses from the drop in Taigen Biopharmaceutica's long position.

The idea behind Citigroup and Taigen Biopharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.